INCYTE CORP·4

May 21, 4:02 PM ET

Clancy Paul J 4

4 · INCYTE CORP · Filed May 21, 2026

Research Summary

AI-generated summary of this filing

Updated

Incyte (INCY) Director Paul J. Clancy Exercises Options, Sells Shares

What Happened

  • Paul J. Clancy, a director of Incyte Corporation (INCY), exercised stock options and immediately sold shares on May 19, 2026. The filing shows he acquired 15,000 shares by exercising options at $84.53 per share (total exercise cost $1,267,950) and sold 15,000 shares in an open market transaction at $94.93 per share for proceeds of $1,423,950. The filing also records a separate 15,000-share derivative disposition at $0, reported in connection with the exercise.

Key Details

  • Transaction date: 2026-05-19; Form 4 filed 2026-05-21 (filed within the usual two-business-day window).
  • Exercise: 15,000 shares at $84.53 = $1,267,950 (acquired).
  • Sale: 15,000 shares at $94.93 = $1,423,950 (disposed).
  • Derivative disposition: 15,000 shares recorded at $0 (disposed) in the same filing.
  • Shares owned after the transaction: not specified in this filing.
  • Footnotes:
    • F1: Includes 2,518 shares issuable under previously reported restricted stock units that have not vested.
    • F2: The option vests in full on the first anniversary of the grant date, or earlier under certain conditions (e.g., next annual meeting or change of control).

Context

  • This sequence (exercise followed by an immediate sale) is commonly a cashless exercise—the insider converts options to shares and sells shares the same day, often to cover the exercise cost and taxes. Such transactions are routine and do not, by themselves, indicate the insider’s long-term view of the company.

Insider Transaction Report

Form 4
Period: 2026-05-19
Transactions
  • Exercise/Conversion

    Common Stock

    2026-05-19$84.53/sh+15,000$1,267,95038,741 total
  • Sale

    Common Stock

    [F1]
    2026-05-19$94.93/sh15,000$1,423,95023,741 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    [F2]
    2026-05-1915,0000 total
    Exercise: $84.53Exp: 2026-05-26Common Stock (15,000 underlying)
Footnotes (2)
  • [F1]Includes an aggregate of 2,518 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
  • [F2]This option vests in full on the first anniversary of the date of grant, or if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the option plan).
Signature
/s/ Elizabeth Feeney, Attorney-In-Fact|2026-05-21

Documents

3 files